Exelixis (NASDAQ:EXEL)

Top Analyst Upgrades and Downgrades: Chipotle, Delphi, Dollar General, Facebook, Ingersoll-Rand, Nike, Okta, Quest Diagnostics and More

The futures were trading slightly lower Monday morning as investors hoped for another solid week of gains from the stock market. With the NCAA Men's Basketball Tournament starting on Thursday, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More

Stocks were indicated to open higher by over 100 points on the Dow Jones industrial average and 10 points on the S&P 500 on developing China trade hopes. With the ...
Read Full Story »

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

If most investors thought their portfolios took a beating during the final quarter of 2018, it was a good thing they were not all-in on the biotechnology segment. The VanEck ...
Read Full Story »

Sears, Exelixis Drop into Monday’s 52-Week Low Club

October 15, 2018: Here are four stocks trading with heavy volume among 212 equities making new 52-week lows in Monday's session. On the NYSE advancers led decliners by about 1.57 ...
Read Full Story »

Exelixis Initiates Key Late-Stage Cancer Trial

Exelixis Inc. (NASDAQ: EXEL) shares dipped on Monday after the company announced that it has initiated a late-stage trial in patients with radioiodine-refractory differentiated thyroid cancer (DTC). This Phase 3 ...
Read Full Story »

JD.com, Exelixis Stumble into Monday’s 52-Week Low Club

September 17, 2018: Here are four stocks trading with heavy volume among 107 equities making new 52-week lows in Monday's session. On the NYSE decliners led advancers by about 1.6 ...
Read Full Story »

Invesco, Chemours Slide into Thursday’s 52-Week Low Club

September 13, 2018: Here are four stocks trading with heavy volume among 102 equities making new 52-week lows in Thursday's session. On the NYSE advancers led decliners by about 1.25 ...
Read Full Story »

Sears, Exelixis Fall into Tuesday’s 52-Week Low Club

August 21, 2018: Here are four stocks trading with heavy volume among 40 equities making new 52-week lows in Tuesday's session. On the NYSE advancers led decliners by about 1.82 ...
Read Full Story »

Exelixis, Lannett Topple into Monday’s 52-Week Low Club

August 20, 2018: Here are four stocks trading with heavy volume among 86 equities making new 52-week lows in Monday's session. On the NYSE advancers led decliners by about 2.32 ...
Read Full Story »

4 Red-Hot Biotech Stocks to Buy Before Earnings

If there is any industry that can blow hot and then very cold on Wall Street, it’s biotechnology, and with good reason. Like big pharmaceuticals, politicians love to target biotechs ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Best Buy, Chipotle, Exact Sciences, Fitbit, Itron, NuVasive, Palo Alto Networks, Stryker and More

Stocks have recovered much of their losses since the sell-off began at the end of January. That being said, there are still roughly 1,000 points on the Dow and roughly ...
Read Full Story »

Exelixis Slides Despite Positive Late-Stage Results

Shares of Exelixis Inc. (NASDAQ: EXEL) slipped on Wednesday after the company reported results from its late-stage trial for advanced hepatocellular carcinoma (HCC). Specifically, this was a pivotal Phase 3 ...
Read Full Story »

Exelixis Wins Big With FDA Approval

Exelixis Inc. (NASDAQ: EXEL) saw its shares make a handy gain on Wednesday after the company was tapped by the U.S. Food and Drug Administration (FDA). Specifically, the FDA has ...
Read Full Story »

9 Major Stock Movers to Watch for Wednesday

With tax reform having cleared the Senate and going back to the House, investors were looking for a higher stock market open on Wednesday, December 20. It's hard to imagine, ...
Read Full Story »

Exelixis Cancer Treatment Hits Key Milestone

Exelixis Inc. (NASDAQ: EXEL) kicked off the week with a couple updates that are already having a big impact on the stock. These updates came in the form of a ...
Read Full Story »